Five Drug Classes Show Promise for Extending Human Healthspan and Reversing Aging
Comprehensive review identifies senolytics, NAD+ precursors, mTOR inhibitors and other compounds targeting aging hallmarks.
Biological age reversal, epigenetic clocks, senolytics, and anti-aging interventions
1,829 articles
Comprehensive review identifies senolytics, NAD+ precursors, mTOR inhibitors and other compounds targeting aging hallmarks.
TET and TDG proteins regulate DNA methylation in T cells, affecting immune responses, inflammation, and age-related diseases.
Go beyond the basics and explore how mTOR actually reads nutrient signals, which molecular players are involved, and why the balance between mTOR complexes determines whether you age faster or slower.
The FDA is piloting live data-streaming in clinical trials, promising faster drug approvals but raising concerns about data quality and bias.
A first-of-its-kind proteomics study finds acute cold exposure shifts 185 circulating proteins in a cardioprotective, anti-aging direction across independent cohorts.
A scoping review exposes deep conceptual gaps in how physical resilience is defined and measured across aging and rehabilitation science.
Research reveals GHK-Cu peptide reduces inflammation and oxidative stress, offering new insights for anti-aging applications.
Discover how your cells decide when to grow and when to repair — and why this ancient biological switch is one of the hottest topics in longevity science.
From NAD+ restoring aged muscle to meal timing accelerating aging, April's research roundup delivers actionable longevity insights.
A new partnership brings standardized spermidine into US clinical settings, shifting longevity science from shelves to physician-guided care.
NorthStrive Biosciences files a patent for EL-22, a myostatin-targeting probiotic designed to prevent muscle loss from GLP-1 drugs and aging.
Genomics pioneer Craig Venter, who accelerated human genome sequencing and founded Human Longevity Inc, has died aged 79.